Professor Mark Frydenberg is a clinical professor in the Department of Surgery, Faculty of Medicine, Monash University; Clinical Chairman, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Faculty of Medicine, Monash University and Chairman, Department of Urology, Monash Health, Melbourne, Victoria, Australia. He is currently the President of the Urological Society of Australia and New Zealand, and was the inaugural chairman, of the Urologic Oncology Special Advisory Group of this organisation.
His main research interests are in the area of Urologic Oncology having published greater than 130 papers on clinical, epidemiological and psycho-oncology/survivorship aspects of all major urological cancers, and has been awarded approximately 10 million dollars in grant funding in urological cancer research over the last 10 years. This included being the principal investigator for the Victorian Cancer Agency funded CAPTIV collaboration ( CAncer of the Prostate Translational research In Victoria ).
He has previously held board membership of Andrology Australia and is currently on the federal board of the Prostate Cancer Foundation of Australia. He is also on the steering committee of both the Victorian and Australian prostate cancer registries. He is on the Executive committee of the World Urologic Oncology Federation, the Australian representative of the Asia-Pacific Society of Uro-Oncology, and is on the editorial board of J Urologic Oncology, and World Journal of Urology and is a regular reviewer for multiple major urologic journals, NHMRC and Prostate Cancer UK.